JP2003246728A5 - - Google Patents

Download PDF

Info

Publication number
JP2003246728A5
JP2003246728A5 JP2002369185A JP2002369185A JP2003246728A5 JP 2003246728 A5 JP2003246728 A5 JP 2003246728A5 JP 2002369185 A JP2002369185 A JP 2002369185A JP 2002369185 A JP2002369185 A JP 2002369185A JP 2003246728 A5 JP2003246728 A5 JP 2003246728A5
Authority
JP
Japan
Prior art keywords
disease
animal
feed
salt
ornithine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002369185A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003246728A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2002369185A priority Critical patent/JP2003246728A/ja
Priority claimed from JP2002369185A external-priority patent/JP2003246728A/ja
Publication of JP2003246728A publication Critical patent/JP2003246728A/ja
Publication of JP2003246728A5 publication Critical patent/JP2003246728A5/ja
Pending legal-status Critical Current

Links

JP2002369185A 2001-12-21 2002-12-20 クロソ蛋白質発現量の減少により引きおこされる疾患の治療または予防剤 Pending JP2003246728A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002369185A JP2003246728A (ja) 2001-12-21 2002-12-20 クロソ蛋白質発現量の減少により引きおこされる疾患の治療または予防剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-389912 2001-12-21
JP2001389912 2001-12-21
JP2002369185A JP2003246728A (ja) 2001-12-21 2002-12-20 クロソ蛋白質発現量の減少により引きおこされる疾患の治療または予防剤

Publications (2)

Publication Number Publication Date
JP2003246728A JP2003246728A (ja) 2003-09-02
JP2003246728A5 true JP2003246728A5 (enExample) 2005-08-18

Family

ID=28677010

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002369185A Pending JP2003246728A (ja) 2001-12-21 2002-12-20 クロソ蛋白質発現量の減少により引きおこされる疾患の治療または予防剤

Country Status (1)

Country Link
JP (1) JP2003246728A (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007031375A (ja) * 2005-07-28 2007-02-08 Kyowa Hakko Kogyo Co Ltd 肌質改善用経口剤
JP2017019726A (ja) * 2015-07-07 2017-01-26 佐々木食品工業株式会社 Elovl6阻害、NASHの予防又は治療並びにインスリン抵抗性改善用組成物
EP4144413A4 (en) * 2020-03-30 2024-04-24 Ajinomoto Co., Inc. COMPOSITION FOR IMPROVING OR PREVENTING DECLINES IN BONE STRENGTH
WO2026038577A1 (ja) * 2024-08-15 2026-02-19 太陽化学株式会社 飲食品摂取後の血中アミノ酸または消化管ホルモン濃度制御用組成物

Similar Documents

Publication Publication Date Title
MY151018A (en) Use of nutritional compositions for preventing disorders
SG135192A1 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
IL219857A0 (en) Mitotic kinesin inhibitors, pharmaceutical compositions comprising them, uses thereof in the manufacture of a medicament for the treatment of disease or disorder in a human or animal that can be treated by inhibiting mitosis
MXPA04005582A (es) Alimento o composicion de alimento para mascotas que contiene extracto de plantas para la salud osea.
EP1356811A4 (en) PROPHYLACTICS OR REMEDIES FOR ARTHRITIS
WO2005007652A3 (en) Substituted quinolin-4-ylamine analogues
WO2007022344A3 (en) Methods and compositions for the preventioin and treatment of kidney disease
WO2009055799A3 (en) Compositions and methods for treatment of diseases of the foot of an animal
WO2020158632A1 (ja) 機能水
WO2004110380A3 (en) Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
WO2006029036A3 (en) Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis
EP1637137A3 (en) Method and composition for administering a cyclooxygenase-2 inhibitor to animals
WO2000035952A3 (en) Compounds for control of eating, growth and body weight
MXPA04000442A (es) Composicion de alimento para mascotas, para regular el peso corporal y evitar la obesidad y trastornos relacionados en mascotas.
DE60101087D1 (de) Gesunde hundefuttermittel
JP2008500376A5 (enExample)
DE60135904D1 (de) Arzneien zur behandlung von nervenerkrankungen
EP1938824A4 (en) MEDICINES, FOOD AND BEVERAGES OR FEEDS CONTAINING SPHINGOMYELIN
WO2005084401A3 (en) Aryl substituted purine analogues
MXPA05009242A (es) Tratamiento de la diabetes tipo 1 con los inhibidores de la pde5.
Motluk It's a wonderful lie
WO2004056768A3 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
PL374083A1 (en) Sgk and nedd used as diagnostic and therapeutic targets
WO2008075333A3 (en) Edible compositions for preventing hair loss
WO2004093867A3 (en) Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use